In this health care podcast, Josh LaRosa from the Wynne Health Group is back to give us an update on the snowball of drug pricing initiatives zigzagging their way around Washington right now. For the details, listen to episode 243. That’s where we really drill into the details. This conversation is more of a status report. (Note: This episode was recorded on February 6.) 

Listen to the podcast here.